Hua Medicine (the Company, HKG: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA...
Hua Medicine (the Company, HKG: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin improves...
Significantly Boosting Market Penetration and Driving Valuation Reassessment
On November 28, the National Healthcare Security Administration (NHSA) and the Ministry of Human Resources and...
Marking Another Milestone in Commercialization
Today, Everest Medicines announced that NEFECON(R) has received full approval from the Ministry of Food and Drug Safety (MFDS)...
Despite Singapore’s abundant sunlight, Vitamin D deficiency remains a prevalent health issue, affecting millions of people. This deficiency significantly compromises bone health, leading to osteoporosis,...
Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on the development of novel...
The 17th “C.C. Tan Life Science Award” ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive...
